Recession in America: When Builders Go Broke

Chicago-based Neumann Homes went bankrupt last November, leaving a trail of wreckage in its path. Its worst victims? Homeowners

Marcial: BioSante May Be Buyout Bait

The biotech's LibiGel, in clinical trials, could make it a player in treating female sexual dysfunction—and draw bids from Big Pharma

Buffett's USG Bet Hits a Wall

The Berkshire CEO doubled down on his stake in the Sheetrock maker in 2006. His gamble has cost him millions

Stovall: The Case for Mid-Caps

Mid-cap stocks are expected to post better earnings growth than their larger counterparts—and may have more upside in a market recovery

Goldman's Profit Prowess

As Goldman Sachs' latest results demonstrate, a worldwide financial crisis isn't tripping up the Wall Street heavyweight. So how does Goldman do it?

Movers: Goldman Sachs, Zions, Best Buy, La-Z-Boy, Elan

Stocks in the news on Tuesday

Analyst Actions: Zions, CME Group, Worthington Industries

Stocks Move Lower

Despite the credit crisis, Goldman Sachs earnings impressed investors. New data showed the threat of inflation

S&P Picks and Pans: Goldman Sachs, Best Buy, Adobe Systems, Vodafone, Elan

Analysts' opinions on stocks in the news Tuesday